Genomic Health (GHDX) is a molecular diagnostics company focused on the global development and commercialization of genomic-based clinical laboratory services that analyze the underlying biology of cancer allowing physicians and patients to make individualized treatment decisions. This stock is trading up 3.4% at $36.63 in recent trading.
Today's Volume: 213,000Average Volume: 157,455 Volume % Change: 118% >>5 Rocket Stocks Ready for Blastoff From a technical perspective, GHDX is moving notably higher here with above-average volume. This move is quickly pushing GHDX within range of triggering a major breakout trade. That trade will hit once GHDX takes out some past overhead resistance levels at $36.81 to $37.44 with high volume. At last check, GHDX has hit an intraday high of $36.68 and volume is just staring to push above its three-month average action of 157,455 shares. Traders should now look for long-biased trades in GHDX as long as it's trending above its 50-day at $34.22, and then once it sustains a move or close above those breakout levels with volume that's near or above 157,455 shares. If that breakout triggers soon, then GHDX will have a great chance of entering new 52-week-high territory and trading north of $40.